Enrollment is now complete in the CORAL clinical trial of nalbuphine ER, to be marketed as Haduvio, for IPF patients with ...

First columnist Sam Kirton's truck malfunctioned. Then he received some unfortunate medical news. It was just one of those days.

CS014 has shown the ability to reverse scarring and ease blood vessel remodeling in a preclinical model of pulmonary arterial hypertension.

Sam Kirton started his column in November 2021 and writes from his home at Lake Anna, Virginia, where he lives with his wife Susan. His diagnosis at age 59 with idiopathic pulmonary fibrosis in ...

Visit the Pulmonary Fibrosis News forums to connect with others in the PF community.

Joining the IPF community may not be voluntary, columnist Sam Kirton says, but he's grateful for the fraternity he's found along the way.

Visit the Pulmonary Fibrosis News forums to connect with others in the PF community.